Neuroactive steroids with perfluorobenzoyl group.

Area of Science:

• Neuroscience
• Organic Chemistry
• Pharmacology

Background:

• Neuroactive steroids modulate neuronal function, particularly through NMDA receptors.
• Developing effective photolabeling agents is crucial for studying neurosteroid interactions.
• Existing photolabeling methods may have limitations in specificity or efficiency.

Purpose of the Study:

• To synthesize and evaluate novel perfluorobenzoate and perfluorobenzamide derivatives of neuroactive steroids.
• To investigate the NMDA receptor inhibitory activity of these new compounds.
• To identify potential candidates for photolabeling applications.

Main Methods:

• Synthesis of perfluorobenzoates and perfluorobenzamides at the 17-position of 5β-androstan-3α-ol.
• Transformation of synthesized compounds into glutamate or sulfate derivatives.
• Assessment of NMDA receptor inhibitory activity through comparative assays.
• Substitution of fluorine with azide in one derivative to evaluate activity retention.

Main Results:

• 17α-epimers exhibited comparable inhibitory activity to natural neurosteroids at NMDA receptors.
• These 17α-epimers were significantly more potent (2- to 36-fold) than their 17β-substituted analogs.
• A derivative with an azide substitution retained activity, indicating potential for photolabeling.
• Four out of nine tested compounds demonstrated significant inhibition, serving as promising leads.

Conclusions:

• Novel perfluorobenzoyl derivatives of neuroactive steroids show potent NMDA receptor inhibition.
• The 17α-epimers are particularly effective and represent valuable tools for neurosteroid research.
• These findings support the development of these compounds as photolabeling agents for studying neurosteroid mechanisms.